News

Stay Updated! In The World Of Investments!
Sensex 48080.67 374.87 (0.79%)

Ranbaxy Labs. Latest News

17

Mar, 2015

Ranbaxy Laboratories submits disclosures

Ranbaxy Laboratories has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

The above information is a part of company’s filings submitted to BSE.&l...

Read More

21

Feb, 2015

Ranbaxy Laboratories submits disclosures

Ranbaxy Laboratories has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

The above information is a part of company’s filings submitted to BSE.&l...

Read More

02

Feb, 2015

Ranbaxy trades higher on the bourses

Ranbaxy Laboratories is currently trading at Rs. 723.40, up by 19.75 points or 2.81% from its previous closing of Rs. 703.65 on the BSE.

The scrip opened at Rs. 706.25 and has touched a high and low of Rs....

Read More

02

Feb, 2015

Ranbaxy, Sun Pharma receives USFTC clearance for proposed acquisition

US Federal Trade Commission (USFTC) has completed its review of the proposed acquisition of Ranbaxy Laboratories by Sun Pharmaceutical Industries and has granted early termination of the waiting period under the Hart-Scott-Rodi...

Read More

29

Jan, 2015

Ranbaxy Laboratories declines on reporting consolidated net loss of Rs 1029.72 crore in Q3

Ranbaxy Laboratories is currently trading at Rs. 689.50, down by 10.25 points or 1.46% from its previous closing of Rs. 699.75 on the BSE.

The scrip opened at Rs. 685.00 and has touched a high and low of R...

Read More

29

Jan, 2015

Ranbaxy Laboratories reports consolidated net loss of Rs 1029.72 crore in Q3

Ranbaxy Laboratories has reported results for third quarter ended December 31, 2013.

The company has reported a net loss of Rs 1420.48 crore for the quarter as compared to net loss of Rs 395.96 crore for t...

Read More

15

Dec, 2014

Ranbaxy Labs advances on launching India’s first NCE, Synriam in African Countries

Ranbaxy Laboratories is currently trading at Rs. 643.80, up by 0.70 points or 0.11 % from its previous closing of Rs. 643.10 on the BSE.

The scrip opened at Rs. 644.90 and has touched a high and low of Rs....

Read More

15

Dec, 2014

Ranbaxy Laboratories launches India's first NCE, Synriam in African Countries

Ranbaxy Laboratories (Ranbaxy) has received the regulatory approval to launch India's first NCE (New Chemical Entity), Synriam (arterolane maleate 150 mg + piperaquine phosphate 750 mg drug) in seven African countries viz....

Read More

11

Dec, 2014

Ranbaxy Laboratories trades in green on BSE

Ranbaxy Laboratories is currently trading at Rs. 647.75, up by 4.85 points or 0.75% from its previous closing of Rs. 642.90 on the BSE.

The scrip opened at Rs. 644.00 and has touched a high and low of Rs. ...

Read More

09

Dec, 2014

Ranbaxy Labs gains after CCI clears Sun-Ranbaxy deal though with riders

Ranbaxy Laboratories is currently trading at Rs. 642.55, up by 17.35 points or 2.78 % from its previous closing of Rs. 625.20 on the BSE.

The scrip opened at Rs. 648.00 and has touched a high and low of Rs...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback